dr. thigpen on ovarian cancer agents not approved by the fda
Published 10 years ago • 88 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:18
dr. thigpen on comparing treatments in ovarian cancer
-
1:27
dr. thigpen discusses comparing treatment options in ovarian cancer
-
0:59
dr. thigpen on pfs as an endpoint in ovarian cancer trials
-
3:13
dr. herzog on the fda approval of olaparib/bevacizumab as frontline maintenance in ovarian cancer
-
1:29
dr. monk on the fda approval of maintenance rucaparib in ovarian cancer
-
10:32
first-line therapy in ovarian cancer
-
4:30
fda approves new ovarian cancer detection drug by purdue researcher
-
0:39
it’s ovarian cancer awareness month #ovariancancer #cancersucks #doctor #fyp #viral
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
1:15
dr. birrer on fda approval of rucaparib in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
50:04
ovarian cancer update - parvin f. peddi, md | ucla health
-
0:58
fda approves new ovarian cancer detection drug by purdue researcher
-
1:58
dr. birrer on the approval process in ovarian cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
1:10
dr. o'malley on fda approval of maintenance rucaparib in ovarian cancer
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
1:15
dr. konner on parp inhibitors in ovarian cancer
-
0:46
teach the b.e.a.c.h.! #ovariancancerawareness #ovariancancer #ovariancancerawarenessmonth #ovarcome